- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-5922
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Microbial biomarkers for immune checkpoint blockade therapy against cancer ; volume:53 ; number:9 ; day:12 ; month:7 ; year:2018 ; pages:999-1005 ; date:9.2018
Journal of gastroenterology ; 53, Heft 9 (12.7.2018), 999-1005, 9.2018
- Creator
-
Adachi, Keishi
- Contributor
-
Tamada, Koji
SpringerLink (Online service)
- DOI
-
10.1007/s00535-018-1492-9
- URN
-
urn:nbn:de:101:1-2018101904352763156254
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Adachi, Keishi
- Tamada, Koji
- SpringerLink (Online service)
Other Objects (12)
A gut microbial signature for combination immune checkpoint blockade across cancer types
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Immune checkpoint inhibitors: recent progress and potential biomarkers
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Prospects for combining immune checkpoint blockade with PARP inhibition
Regulatory T cells in immune checkpoint blockade antitumor therapy
A gut microbial signature for combination immune checkpoint blockade across cancer types
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Immune checkpoint inhibitors: recent progress and potential biomarkers
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Prospects for combining immune checkpoint blockade with PARP inhibition
Regulatory T cells in immune checkpoint blockade antitumor therapy
A gut microbial signature for combination immune checkpoint blockade across cancer types
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Immune checkpoint inhibitors: recent progress and potential biomarkers
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Prospects for combining immune checkpoint blockade with PARP inhibition